Hello, everyone, nice to see you this morning. And a shiny one it is here on the Pharmalot corporate campus, where the coffee kettle is whistling up a storm. What will today hold in store? We never know, but we are doing our best to keep busy by rifling through documents and talking to interesting people. Meanwhile, deadlines and meetings loom. So have a good day and stay in touch...
Pfizer Launches Media Review (AdWeek)
Sanofi's Limb Ischemia Drug Failed Phase III (PharmaTimes)
Shire Moves Closer To Movetis Takeover (Reuters)
Payday For Whistleblower And His Lawyer (RichmondBizSense)
Study Links Antipsychotics To Clot Risk (Reuters)
Vivus Reports Positive Diet Drug Data (The Wall Street Journal)
ImmunoGen Starts Study For Cancer Treatment (MassHighTech)